Bio-Rad Laboratories Inc (BIO)
350.23
-12.97
(-3.57%)
USD |
NYSE |
Nov 14, 16:00
351.79
+1.56
(+0.45%)
Pre-Market: 07:03
Bio-Rad Laboratories Cash from Financing (Quarterly): -95.99M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -95.99M |
| June 30, 2024 | -96.59M |
| March 31, 2024 | 0.021M |
| December 31, 2023 | -200.62M |
| September 30, 2023 | -26.60M |
| June 30, 2023 | -202.74M |
| March 31, 2023 | 4.309M |
| December 31, 2022 | -86.62M |
| September 30, 2022 | -8.772M |
| June 30, 2022 | -121.33M |
| March 31, 2022 | 1.190B |
| December 31, 2021 | 4.635M |
| September 30, 2021 | -15.58M |
| June 30, 2021 | 2.865M |
| March 31, 2021 | -47.35M |
| December 31, 2020 | -421.88M |
| September 30, 2020 | 0.439M |
| June 30, 2020 | -2.979M |
| March 31, 2020 | -98.62M |
| December 31, 2019 | -4.783M |
| September 30, 2019 | -4.491M |
| June 30, 2019 | -15.64M |
| March 31, 2019 | 2.161M |
| December 31, 2018 | -47.00M |
| September 30, 2018 | -2.176M |
| Date | Value |
|---|---|
| June 30, 2018 | -2.016M |
| March 31, 2018 | 2.515M |
| December 31, 2017 | 3.576M |
| September 30, 2017 | -2.84M |
| June 30, 2017 | -1.068M |
| March 31, 2017 | 0.673M |
| December 31, 2016 | 2.829M |
| September 30, 2016 | 2.897M |
| June 30, 2016 | 3.036M |
| March 31, 2016 | 0.258M |
| December 31, 2015 | 3.728M |
| September 30, 2015 | 2.123M |
| June 30, 2015 | 3.061M |
| March 31, 2015 | -0.331M |
| December 31, 2014 | 3.625M |
| September 30, 2014 | 1.766M |
| June 30, 2014 | 2.808M |
| March 31, 2014 | 3.49M |
| December 31, 2013 | 3.768M |
| September 30, 2013 | -309.33M |
| June 30, 2013 | 1.29M |
| March 31, 2013 | -7.426M |
| December 31, 2012 | 3.515M |
| September 30, 2012 | 2.554M |
| June 30, 2012 | 2.80M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-421.88M
Minimum
Dec 2020
1.190B
Maximum
Mar 2022
-11.39M
Average
-21.09M
Median
Cash from Financing (Quarterly) Benchmarks
| Agilent Technologies Inc | -246.00M |
| Bruker Corp | -2.70M |
| Azenta Inc | -224.44M |
| Harvard Bioscience Inc | 2.104M |
| Bionano Genomics Inc | -1.978M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 163.61M |
| Cash from Investing (Quarterly) | -55.64M |
| Free Cash Flow | 223.75M |
| Free Cash Flow Per Share (Quarterly) | 3.572 |
| Free Cash Flow to Equity (Quarterly) | 88.91M |
| Free Cash Flow to Firm (Quarterly) | 99.97M |
| Free Cash Flow Yield | 2.25% |